Vitamin D: RDI under review
By: Sarah Calder, Regulatory Affairs Specialist, email The Therapeutic Products Directorate has announced it will review the existing level of Vitamin D on the Prescription Drug... Read More
Canadian Microbeads in Toiletries Regulations
By: Teri Dickinson, Manager Regulatory Affairs Group, email In June 2017, the Microbeads in Toiletries Regulations were published in the Canada Gazette, Part II: Vol. 151,... Read More
Fee Proposal for Drugs and Medical Devices
Fee Proposal for Drugs and Medical Devices Published for Consultation By: Teri Dickinson, Manager Regulatory Affairs Group, email On May 24th, 2018 published the revised proposal... Read More
Sunscreen Ban in Hawaii
By: Sarah Calder, Regulatory Affairs Specialist, email On May 1, 2018 a bill was passed in the State of Hawaii legislature to ban the common ingredients found... Read More
R-ICL Review
Update: Revised In Commerce List (R-ICL) By: Teri Dickinson, Manager, Regulatory Affairs Specialist, email On April 7, 2018, the Notice of Intent announcing the closure of... Read More
Health Canada Reclassifies Disinfectants
High Level Disinfectants Reclassified…Be in the know By: Sarah Calder, Regulatory Affairs Specialist, email Last month Health Canada released a notice of the reclassification of high-level disinfectants... Read More
Administrative Din: NEW RULES
NEW RULES FOR ADMINISTRATIVE PROCESSING OF DIN SUBMISSIONS COMING MARCH 1, 2018 By: Teri Dickinson, Manager, Regulatory Affairs Group, email On December 13, 2017 Health Canada... Read More
Health Canada: Fee Increase Proposal
Fee Proposal for Drugs and Medical Devices Published for Consultation By: Teri Dickinson Jenner, Manager, Regulatory Affairs Group, email Budget 2017 signalled the Government of Canada’s... Read More
Plain Language Labelling Regulations for Non-Prescription Drugs
Updating Canada’s PLL Regulations By: Vicki Schofield, Regulatory Affairs Specialist, email Beginning June 13, 2017, Plain Language Labelling Regulations came into effect for non-prescription drugs. The intention of... Read More
5 Methylenediphenyl diisocyanates (MDI) proposed to be declared Toxic in Canada
By: Joe McCarthy, Senior regulatory Affairs Specialist, email Environment Canada has published a proposed amendment that 5 MDI substances (101-68-8; 2536-05-2, 5873-54-1; 9016-87-9 and 26447-40-5) be... Read More